They observed that PTEN deficiency increased the osteoclast development in vivo and in vitro by enhancing the expression of the RANKL‐induced osteoclast transcription factor, and in a human TNF‐transgenic arthritis model, there was increased local osteoclast activity in the joints. This evidence concerns the gene TNFSF11 and arthritic joint disease.